Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Shelley Wood

November 06, 2022

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Shelley Wood

November 01, 2021

News Conference News ACC 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Yael L. Maxwell

May 26, 2021

News Conference News AHA 2020

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

Caitlin E. Cox

November 20, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Shelley Wood

March 30, 2020

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Conference News AHA 2018

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Caitlin E. Cox

November 11, 2018

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Daily News

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

Todd Neale

April 10, 2017

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Todd Neale

March 11, 2015

News Daily News

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

Jason Kahn

April 12, 2013

News Daily News

El Tratamiento basado en la Isquemia No Altera la Mortalidad en Pacientes Postrevascularizados

Jason Kahn

April 12, 2013

News Daily News

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

L.A. McKeown

October 28, 2011

Advertisement

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

ISCHEMIA Questions? Some Answers From David Maron

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

El Tratamiento basado en la Isquemia No Altera la Mortalidad en Pacientes Postrevascularizados

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content